Ohcanbohtosat - Jens Claaßen
- Čájehuvvo 1 - 9 / 9
-
1
Effect of chlorzoxazone in patients with downbeat nystagmus Dahkki Katharina Feil, Jens Claaßen, Stanislavs Bardins, Julian Teufel, S. Krafczyk, Erich Schneider, Roman Schniepp, Klaus Jahn, Roger Kalla, Michael Strupp
Almmustuhtton 2013Artigo -
2
Comparison of 10-mg Doses of 4-Aminopyridine and 3,4-Diaminopyridine for the Treatment of Downbeat Nystagmus Dahkki Roger Kalla, Rainer Spiegel, Jens Claaßen, Stanislavs Bardins, Aleš Hahn, Erich Schneider, N. Rettinger, Stefan Glasauer, Thomas Brandt, Michael Strupp
Almmustuhtton 2011Artigo -
3
A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus—effects on slowphase eye velocity, postural stability, locomotion and symptoms Dahkki Jens Claaßen, Rainer Spiegel, Roger Kalla, Mary Faldon, Christopher Kennard, Chotipat Danchaivijitr, Stanislaw Bardins, N. Rettinger, Erich Schneider, Thomas Brandt, Klaus Jahn, Julian Teufel, Michael Strupp, Adolfo M. Bronstein
Almmustuhtton 2013Artigo -
4
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias Dahkki Michael Strupp, R. Kalla, Jens Claaßen, Christine Adrion, Ulrich Mansmann, Thomas Klopstock, Tobias Freilinger, Hermann Neugebauer, Rainer Spiegel, Martin Dichgans, F. Lehmann‐Horn, Karin Jurkat‐Rott, T. Brandt, Joanna C. Jen, Klaus Jahn
Almmustuhtton 2011Artigo -
5
Consensus Paper: Management of Degenerative Cerebellar Disorders Dahkki Winfried Ilg, Amy J. Bastian, Sylvia Boesch, Roxana G. Burciu, Pablo Celnik, Jens Claaßen, Katharina Feil, R. Kalla, Ichiro Miyai, Wolfgang Nachbauer, Lüdger Schöls, Michael Strupp, Matthis Synofzik, Julian Teufel, Dagmar Timmann
Almmustuhtton 2013Artigo -
6
Efficacy and Safety of N-Acetyl- <scp>l</scp> -Leucine in Children and Adults With GM2 Gangliosidoses Dahkki Κyriakos Martakis, Jens Claaßen, Jordi Gascon-Bayari, Nicolina Goldschagg, Andreas Hahn, Anhar Hassan, Anita Hennig, Simon Jones, R. Kay, Heather Lau, Susan Perlman, Reena Sharma, Susanne A. Schneider, Tatiana Brémovà-Ertl
Almmustuhtton 2022Artigo -
7
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C Dahkki Tatiana Brémovà-Ertl, Jens Claaßen, Tomas Foltan, Jordi Gascón‐Bayarri, Paul Gissen, Andreas Hahn, Anhar Hassan, Anita Hennig, Simon Jones, Miriam Kolníková, Κyriakos Martakis, Jan Raethjen, Uma Ramaswami, Reena Sharma, Susanne A. Schneider
Almmustuhtton 2021Artigo -
8
GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort Dahkki David Pellerin, Felix Heindl, Carlo Wilke, Matt C. Danzi, Andreas Traschütz, Catherine Ashton, Marie‐Josée Dicaire, Alexanne Cuillerier, Giulia Gobbo, Kym M. Boycott, Jens Claaßen, Dan Rujescu, Annette M. Hartmann, Stephan Züchner, Bernard Brais, Michael Strupp, Matthis Synofzik
Almmustuhtton 2024Artigo -
9
Multisystemic<i>SYNE1</i>ataxia: confirming the high frequency and extending the mutational and phenotypic spectrum Dahkki Inès Mademan, Florian Harmuth, Ilaria Giordano, Dagmar Timmann, Stefania Magri, Tine Deconinck, Jens Claaßen, Daniel Jokisch, Gençer Genç, Daniela Di Bella, Silvia Romito, Rebecca Schüle, Stephan Züchner, Franco Taroni, Thomas Klockgether, Lüdger Schöls, Peter De Jonghe, Peter Bauer, EOA Consortium, Jonathan Baets, Matthis Synofzik
Almmustuhtton 2016Carta
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Ataxia
Audiology
4-Aminopyridine
Nystagmus
Pathology
Potassium channel
Psychiatry
Alternative medicine
Cerebellar ataxia
Pediatrics
Placebo
Anesthesia
Cerebellum
Clinical endpoint
Clinical trial
Crossover study
Disease
Intention tremor
Neuroscience
Nursing
Quality of life (healthcare)
Adverse effect
Amyotrophic lateral sclerosis
Balance (ability)
Biology
CYP2E1
Cerebellar Degeneration
Chlorzoxazone